Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avagacestat in Prodromal Alzheimer's Disease
NCT00890890Phase 2Terminated
- Sponsor
- Bristol Myers Squibb
- Start
- May 2009
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of avagacestat in Alzheimer's disease (AD), sponsored by Bristol Myers Squibb. Started May 2009; status: terminated.
02
Drugs
avagacestat
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00890890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00890890.